1. Home
  2. CERS vs QUAD Comparison

CERS vs QUAD Comparison

Compare CERS & QUAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • QUAD
  • Stock Information
  • Founded
  • CERS 1991
  • QUAD 1971
  • Country
  • CERS United States
  • QUAD United States
  • Employees
  • CERS N/A
  • QUAD N/A
  • Industry
  • CERS EDP Services
  • QUAD Publishing
  • Sector
  • CERS Technology
  • QUAD Consumer Discretionary
  • Exchange
  • CERS Nasdaq
  • QUAD Nasdaq
  • Market Cap
  • CERS 347.3M
  • QUAD 300.1M
  • IPO Year
  • CERS 1997
  • QUAD 2010
  • Fundamental
  • Price
  • CERS $1.27
  • QUAD $5.83
  • Analyst Decision
  • CERS Strong Buy
  • QUAD Strong Buy
  • Analyst Count
  • CERS 2
  • QUAD 2
  • Target Price
  • CERS $3.50
  • QUAD $9.45
  • AVG Volume (30 Days)
  • CERS 1.2M
  • QUAD 364.5K
  • Earning Date
  • CERS 05-01-2025
  • QUAD 07-29-2025
  • Dividend Yield
  • CERS N/A
  • QUAD 5.15%
  • EPS Growth
  • CERS N/A
  • QUAD N/A
  • EPS
  • CERS N/A
  • QUAD N/A
  • Revenue
  • CERS $185,144,000.00
  • QUAD $2,646,800,000.00
  • Revenue This Year
  • CERS $22.37
  • QUAD N/A
  • Revenue Next Year
  • CERS $8.46
  • QUAD N/A
  • P/E Ratio
  • CERS N/A
  • QUAD N/A
  • Revenue Growth
  • CERS 13.06
  • QUAD N/A
  • 52 Week Low
  • CERS $1.12
  • QUAD $4.06
  • 52 Week High
  • CERS $2.54
  • QUAD $9.13
  • Technical
  • Relative Strength Index (RSI)
  • CERS 46.48
  • QUAD 55.33
  • Support Level
  • CERS $1.21
  • QUAD $5.12
  • Resistance Level
  • CERS $1.35
  • QUAD $6.10
  • Average True Range (ATR)
  • CERS 0.06
  • QUAD 0.25
  • MACD
  • CERS -0.00
  • QUAD 0.01
  • Stochastic Oscillator
  • CERS 38.89
  • QUAD 71.00

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

Share on Social Networks: